Connect with us

Published

on

A popular prescription anxiety drug is being recalled nationwide for a “possibly life-threatening” mistake on the carton.

The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code.

The new recall affects 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV), with doses ranging from 0.125 milligrams to 2 milligrams.

The packages feature 10 blister strips that each contain six tablets.

They are due to expire between August 2026 and February 2027.

Clonazepam is a benzodiazepine used to treat panic disorder and certain types of seizures.

Endo warns that consuming a higher dose of clonazepam could increase the risk of sleepiness, confusion, dizziness, diminished reflexes and loss of muscle control or strength.

There’s also the risk of “significant, possibly life-threatening” breathing troubles, especially for those with respiratory disease, those being prescribed the maximum dose and those taking other medications that affect breathing.

Endo reports that as of Monday, it has not received any reports of problems stemming from the recall.

The pharmaceutical company announced its initial recall in July of just one lot of clonazepam.

At the time, Endo blamed an “error at a third-party packager” for the mislabeling.

Some cartons showed the product strength as 0.125 mg and not 0.25 mg.

The blister strips inside the package reflected the correct strength, Endo said.

The recalled cartons also list Par Pharmaceuticalof New York as the distributor.

The company, based in Chestnut Ridge, marketed clonazepam before the product was acquired by Endo.

Subscribe to our weekly Post Care newsletter!

Please provide a valid email address.

By clicking above you agree to the Terms of Use and Privacy Policy.

Never miss a story.

People with questions about the recall should call (855) 589-1869 or email rxrecalls@inmar.com.

Retailers with these products are being directed not to sell them, while consumers shouldn’t take them. Consult a physician if you believe you took an incorrect dose of clonazepam.

Continue Reading

Politics

US crypto legislation and policies to watch out for in 2026

Published

on

By

US crypto legislation and policies to watch out for in 2026

Many crypto industry leaders and users anticipate significant changes in the US regulatory environment over the next 12 months, as various policy changes and legislation begin to take effect.

Although the inauguration of US President Donald Trump in January 2025 did not mean an immediate end to all digital asset regulation, many of the administration’s policies, from dismissing enforcement cases of crypto companies by the Securities and Exchange Commission to signing a stablecoin bill into law, signal apparent differences to previous US presidents and their chosen regulators.

“I expect an increasing number of jurisdictions to establish clear and transparent regulatory frameworks for the crypto industry, which should facilitate broader participation,” Ruslan Lienkha, YouHodler’s chief of markets, said in a statement shared with Cointelegraph. “Consequently, we are likely to see a significant rise in the involvement of banks and other financial institutions in the market in 2026.”

Digital asset market structure

As of late December, the US Senate has yet to vote on legislation to establish clear regulatory guidelines for digital assets. 

The initial bill, known as the Digital Asset Market Clarity Act (CLARITY), was passed by the House of Representatives in July. However, lawmakers in the Senate said their versions of the legislation would “build on” the existing bill rather than passing it through the chamber without any changes.

As a result, leadership on the Senate Banking Committee released a Republican-led discussion draft of the bill in July, and the Senate Agriculture Committee announced a bipartisan draft in November. Both bills will need to go through the respective committees before the full chamber can vote on either, or some combination thereof. 

The drafts suggested that Congress could grant the Commodity Futures Trading Commission more authority to regulate digital assets. The Securities and Exchange Commission has taken on a more prominent role in overseeing cryptocurrencies, with some notable exceptions. 

According to digital asset management company Grayscale, the bill will “facilitate deeper integration between public blockchains and traditional finance, facilitate regulated trading of digital asset securities, and potentially allow for onchain issuance by both startups and mature firms.”

Related: Republicans urge action on market structure bill over debanking claims

Both agencies have filed enforcement actions and issued rulemaking affecting the industry, but the SEC oversees exchange-traded funds tied to digital assets. The CFTC regulates Bitcoin (BTC) and Ether (ETH) as commodities in digital form.

Implementation of the GENIUS stablecoin act

One of the other pieces of legislation to emerge from a Republican-led US Congress in 2025 was the GENIUS Act, which aimed to establish a regulatory framework for payment stablecoins. Although Trump signed the bill into law in July 2025, it will take effect either 18 months after enactment or 120 days after regulators approve regulations related to implementation, putting the timeline in 2026 or later.

As part of the implementation process, the US Treasury Department opened two rounds of comments for proposed rules related to the GENIUS Act in August and September. The notice of proposed rulemaking could be made public in the first half of 2026, according to some experts.

“As regulatory clarity solidifies, particularly through laws like the GENIUS Act that establish federal stablecoin oversight, banks are increasingly exploring onchain tooling that could transform payments, settlements and liquidity provisioning,” Gracy Chen, CEO of Bitget, said in a statement shared with Cointelegraph. “Should major US banks begin issuing compliant stablecoins or tokenized deposits, we could see significant expansion of global liquidity, faster transaction settlement times, and richer DeFi composability built on regulated infrastructure.”

In addition to the Treasury, other US banking regulators have put forward proposals for stablecoin rules. On Dec. 16, the Federal Deposit Insurance Corporation (FDIC) proposed that subsidiaries of supervised banks could issue payment stablecoins under the criteria passed under GENIUS.

CFTC leadership yet to be named by Trump

In 2025, four out of the five commissioners serving as the CFTC’s leadership stepped down, leaving only Republican Caroline Pham to serve as the acting chair and the agency’s sole commissioner as of December. 

Although Trump initially nominated former CFTC Commissioner Brian Quintenz to replace Pham as a Senate-confirmed chair of the agency, the White House pulled him from consideration in September, reportedly in response to pushback from Gemini co-founders Tyler and Cameron Winklevoss, who are both Trump donors and prominent figures in the crypto industry. 

The withdrawal of Quintenz paved the way for Trump to nominate SEC official Michael Selig as CFTC chair. Selig’s nomination advanced out of the Senate Agriculture Committee in November, and in the full chamber later confirmed him as chair in a 53 to 43 vote as part of a package of nominees.

As of December, Trump has not publicly announced any potential replacements for the four remaining CFTC commissioner seats, despite many of them being vacant for months.

State-level crypto reserves

In June, Texas Governor Gregg Abbot signed a bill into law creating a state-managed fund that could hold Bitcoin (BTC), making the state the first to establish a crypto reserve. State officials announced in November that the fund held $5 million worth of shares in BlackRock’s spot Bitcoin ETF with plans to invest an additional $5 million directly in BTC, a move that could come in 2026.